Atherosclerosis or atheroscleritis: What's in a name?

Cardiology

Volumn 98, Issue 3, 2002, Pages 111-112

  Simon, Harvey B ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTITHROMBOCYTIC AGENT; C REACTIVE PROTEIN; LOW DENSITY LIPOPROTEIN; MACROLIDE; NONSTEROID ANTIINFLAMMATORY AGENT; STATIN;

ANTIINFLAMMATORY ACTIVITY; ATHEROSCLEROSIS; CARDIOVASCULAR RISK; CHLAMYDOPHILA PNEUMONIAE; CLINICAL PRACTICE; CORONARY ARTERY DISEASE; EDITORIAL; HUMAN; INFLAMMATION; NONHUMAN; PRIORITY JOURNAL; VASCULAR DISEASE;

ACUTE-PHASE PROTEINS; ANTI-INFLAMMATORY AGENTS; C-REACTIVE PROTEIN; CAROTID ARTERY DISEASES; CORONARY ARTERIOSCLEROSIS; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; INFLAMMATION MEDIATORS; LIPOPROTEINS, LDL; TERMINOLOGY;

EID: 0036976627     PISSN: 00086312     EISSN: None     Source Type: Journal    
DOI: 10.1159/000066323     Document Type: Editorial

References (13)

1. Munford RS: Statins and the acute-phase response. N Engl J Med 2001;344:2016-2018.
2. Danesh J, Collins R, Appleby P, Peto R: Association of fibrinogen, C-reactive protein, albumin, or leukocyte count with coronary artery disease. Meta-analysis of prospective studies. JAMA 1998;279:147-1482.
3. Hoffmeister A, Rothenbacher D, Bäzner U, Frölich, Brenner H, Hombach V, Koenig W: Role of novel markers of inflammation in patients with stable coronary heart disease. Am J Cardiol 2001;87:262-266.
4. Pasceri V, Willerson JT, Yeh TH: Direct proin-flammatory effect of C-reactive protein on human endothelial cells. Circulation 2000;102:2165-2168.
5. Zwaka TP, Hombach V, Torzewski J: C-reactive protein-mediated low density lipoprotein uptake by macrophages. Circulation 2001;103:1194-1197.
6. Albert MA, Danielson E, Rifai N, Ridker PM for the PRINCE Investigators: Effect of statin therapy on C-reactive protein levels. The pravastatin inflammation/CRP evaluation (PRINCE): A randomized trial and cohort study. JAMA 2001;286:64-70.
7. Ridker PM, Cushman M, Stampfer MJ, Tracy RP, Hennekens CH: Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. N Engl J Med 1997;336:973-979.
8. Levinson SS, Elin RJ: What is C-reactive protein telling us about coronary artery disease? Arch Intern Med 2002;162:389.
9. Rost NA, Wolf PA, Kase CS, et al: Plasma concentration of C-reactive protein and risk of ischemic stroke and transient ischemic attack. The Framingham Study, Stroke 2001;32:2575.
10. Zebrack JS, Anderson JL. Maycock CA, et al: Usefulness of high-sensitivity C-reactive protein in predicting long-term risk of death or acute myocardial infarction in patients with unstable or stable angina pectoris or acute myo-cardial infarction. Am J Cardiol 2002;89:145.
11. Ridker PM, Hennekens CH, Buring JE, Rifai N: C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N Engl J Med 2000;342:836-843.
12. Ridker PM, Rifai N, Clearfield M, Downs JR, Weis SE, Miles JS, Gotto AM Jr for the Air Force/Texas Coronary Atherosclerosis Prevention Study Investigation. N Engl J Med 2001;344:1959-1965.
13. Eidelman RS, Lamas GA, Hennekens CH, Ridker PM: Aspirin, postmenopausal hormones, and C-reactive protein. Arch Intern Med 2002;162:480.